{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:49:05Z","timestamp":1784684945473,"version":"3.55.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40272-017-0250-4","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T09:11:56Z","timestamp":1501665116000},"page":"553-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy"],"prefix":"10.1007","volume":"19","author":[{"given":"Elissa","family":"Yozawitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit M.","family":"Pressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"issue":"14","key":"250_CR1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/WNL.0000000000000282","volume":"82","author":"HC Glass","year":"2014","unstructured":"Glass HC, et al. Risk factors for EEG seizures in neonates treated with hypothermia: a multicenter cohort study. Neurology. 2014;82(14):1239\u201344.","journal-title":"Neurology"},{"issue":"Suppl 3","key":"250_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/dmcn.12724","volume":"57","author":"J Shetty","year":"2015","unstructured":"Shetty J. Neonatal seizures in hypoxic-ischaemic encephalopathy\u2013risks and benefits of anticonvulsant therapy. Dev Med Child Neurol. 2015;57(Suppl 3):40\u20133.","journal-title":"Dev Med Child Neurol"},{"key":"250_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/B978-1-4160-3995-2.10005-6","volume-title":"Neurology of the Newborn","author":"J Volpe","year":"2008","unstructured":"Volpe J. Neonatal Seizures. In: Volpe J, editor. Neurology of the Newborn. WB Saunders: Philadelphia; 2008. p. 203\u201344."},{"issue":"4","key":"250_CR4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1203\/00006450-200110000-00005","volume":"50","author":"EC Wirrell","year":"2001","unstructured":"Wirrell EC, et al. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res. 2001;50(4):445\u201354.","journal-title":"Pediatr Res"},{"issue":"5","key":"250_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000069049","volume":"24","author":"JY Yager","year":"2002","unstructured":"Yager JY, et al. Prolonged neonatal seizures exacerbate hypoxic-ischemic brain damage: correlation with cerebral energy metabolism and excitatory amino acid release. Dev Neurosci. 2002;24(5):367\u201381.","journal-title":"Dev Neurosci"},{"key":"250_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fped.2016.00083","volume":"4","author":"S Mitra","year":"2016","unstructured":"Mitra S, et al. Changes in cerebral oxidative metabolism during neonatal seizures following hypoxic-ischemic brain injury. Front Pediatr. 2016;4:83.","journal-title":"Front Pediatr"},{"issue":"4","key":"250_CR7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.58.4.542","volume":"58","author":"SP Miller","year":"2002","unstructured":"Miller SP, et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology. 2002;58(4):542\u20138.","journal-title":"Neurology"},{"issue":"3","key":"250_CR8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpeds.2009.03.040","volume":"155","author":"HC Glass","year":"2009","unstructured":"Glass HC, et al. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr. 2009;155(3):318\u201323.","journal-title":"J Pediatr"},{"issue":"4","key":"250_CR9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/NEN.0000000000000056","volume":"73","author":"IA Schiering","year":"2014","unstructured":"Schiering IA, et al. Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia. J Neuropathol Exp Neurol. 2014;73(4):324\u201334.","journal-title":"J Neuropathol Exp Neurol"},{"key":"250_CR10","doi-asserted-by":"crossref","unstructured":"Glass HC, et al. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr. 2016;174:98\u2013103 e1.","DOI":"10.1016\/j.jpeds.2016.03.035"},{"issue":"12","key":"250_CR11","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.37.12.1837","volume":"37","author":"EM Mizrahi","year":"1987","unstructured":"Mizrahi EM, Kellaway P. Characterization and classification of neonatal seizures. Neurology. 1987;37(12):1837\u201344.","journal-title":"Neurology"},{"issue":"9","key":"250_CR12","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/j.1528-1167.2009.02132.x","volume":"50","author":"A Malone","year":"2009","unstructured":"Malone A, et al. Interobserver agreement in neonatal seizure identification. Epilepsia. 2009;50(9):2097\u2013101.","journal-title":"Epilepsia"},{"issue":"4","key":"250_CR13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0887-8994(02)00621-5","volume":"28","author":"MS Scher","year":"2003","unstructured":"Scher MS, et al. Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatr Neurol. 2003;28(4):277\u201380.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"250_CR14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/WNP.0b013e31823e96d7","volume":"28","author":"RA Shellhaas","year":"2011","unstructured":"Shellhaas RA, et al. The American Clinical Neurophysiology Society\u2019s guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol. 2011;28(6):611\u20137.","journal-title":"J Clin Neurophysiol"},{"issue":"4","key":"250_CR15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1542\/peds.2007-0514","volume":"120","author":"RA Shellhaas","year":"2007","unstructured":"Shellhaas RA, Soaita AI, Clancy RR. Sensitivity of amplitude-integrated electroencephalography for neonatal seizure detection. Pediatrics. 2007;120(4):770\u20137.","journal-title":"Pediatrics"},{"issue":"6","key":"250_CR16","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1542\/peds.2007-1839","volume":"121","author":"DK Shah","year":"2008","unstructured":"Shah DK, et al. Accuracy of bedside electroencephalographic monitoring in comparison with simultaneous continuous conventional electroencephalography for seizure detection in term infants. Pediatrics. 2008;121(6):1146\u201354.","journal-title":"Pediatrics"},{"issue":"4","key":"250_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475\u201382.","journal-title":"Epilepsia"},{"issue":"7","key":"250_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1440-1754.2005.00638.x","volume":"41","author":"KB Carmo","year":"2005","unstructured":"Carmo KB, Barr P. Drug treatment of neonatal seizures by neonatologists and paediatric neurologists. J Paediatr Child Health. 2005;41(7):313\u20136.","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"250_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2007.04.003","volume":"37","author":"AI Bartha","year":"2007","unstructured":"Bartha AI, et al. Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol. 2007;37(2):85\u201390.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"250_CR20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pediatrneurol.2008.03.003","volume":"38","author":"H Bassan","year":"2008","unstructured":"Bassan H, et al. Neonatal seizures: dilemmas in workup and management. Pediatr Neurol. 2008;38(6):415\u201321.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"250_CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0883073808321056","volume":"24","author":"HK Blume","year":"2009","unstructured":"Blume HK, Garrison MM, Christakis DA. Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals. J Child Neurol. 2009;24(2):148\u201354.","journal-title":"J Child Neurol"},{"issue":"4","key":"250_CR22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1651-2227.2009.01659.x","volume":"99","author":"M Vento","year":"2010","unstructured":"Vento M, et al. Approach to seizures in the neonatal period: a European perspective. Acta Paediatr. 2010;99(4):497\u2013501.","journal-title":"Acta Paediatr"},{"issue":"1","key":"250_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejpn.2012.09.001","volume":"17","author":"R Wickstrom","year":"2013","unstructured":"Wickstrom R, Hallberg B, Bartocci M. Differing attitudes toward phenobarbital use in the neonatal period among neonatologists and child neurologists in Sweden. Eur J Paediatr Neurol. 2013;17(1):55\u201363.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"250_CR24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/adc.2010.191940","volume":"96","author":"S Conroy","year":"2011","unstructured":"Conroy S. Association between licence status and medication errors. Arch Dis Child. 2011;96(3):305\u20136.","journal-title":"Arch Dis Child"},{"issue":"3","key":"250_CR25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.2013-4060","volume":"133","author":"DA Frattarelli","year":"2014","unstructured":"Frattarelli DA, et al. Off-label use of drugs in children. Pediatrics. 2014;133(3):563\u20137.","journal-title":"Pediatrics"},{"issue":"2","key":"250_CR26","doi-asserted-by":"crossref","first-page":"F152","DOI":"10.1136\/adc.2002.023093","volume":"89","author":"P Shah","year":"2004","unstructured":"Shah P, et al. Multiorgan dysfunction in infants with post-asphyxial hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2004;89(2):F152\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"250_CR27","doi-asserted-by":"publisher","unstructured":"Booth D, Evans DJ. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev. 2004;(4):CD004218. doi: 10.1002\/14651858.CD004218.pub2 .","DOI":"10.1002\/14651858.CD004218.pub2"},{"issue":"3","key":"250_CR28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0883073812470734","volume":"28","author":"LA Slaughter","year":"2013","unstructured":"Slaughter LA, Patel AD, Slaughter JL. Pharmacological treatment of neonatal seizures: a systematic review. J Child Neurol. 2013;28(3):351\u201364.","journal-title":"J Child Neurol"},{"key":"250_CR29","unstructured":"Guidelines on Neonatal Seizures. Geneva: World Health Organization; 2011. Available from http:\/\/apps.who.int\/iris\/bitstream\/10665\/77756\/1\/9789241548304_eng.pdf?ua=1 ."},{"issue":"1","key":"250_CR30","first-page":"31","volume":"17","author":"JK Tulloch","year":"2012","unstructured":"Tulloch JK, Carr RR, Ensom MH. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Pharmacol Ther. 2012;17(1):31\u201344.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"250_CR31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1203\/PDR.0b013e3181d4ff4d","volume":"67","author":"JD Barks","year":"2010","unstructured":"Barks JD, et al. Phenobarbital augments hypothermic neuroprotection. Pediatr Res. 2010;67(5):532\u20137.","journal-title":"Pediatr Res"},{"issue":"2","key":"250_CR32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3476(98)70458-5","volume":"132","author":"RT Hall","year":"1998","unstructured":"Hall RT, Hall FK, Daily DK. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr. 1998;132(2):345\u20138.","journal-title":"J Pediatr"},{"issue":"1","key":"250_CR33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","volume":"9","author":"M Bialer","year":"2010","unstructured":"Bialer M, White HS. Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov. 2010;9(1):68\u201382.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"250_CR34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuron.2009.08.022","volume":"63","author":"J Glykys","year":"2009","unstructured":"Glykys J, et al. Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures. Neuron. 2009;63(5):657\u201372.","journal-title":"Neuron"},{"issue":"22","key":"250_CR35","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1523\/JNEUROSCI.3482-15.2016","volume":"36","author":"G Valeeva","year":"2016","unstructured":"Valeeva G, et al. An optogenetic approach for investigation of excitatory and inhibitory network GABA actions in mice expressing channelrhodopsin-2 in GABAergic neurons. J Neurosci. 2016;36(22):5961\u201373.","journal-title":"J Neurosci"},{"issue":"3","key":"250_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000457157","volume":"7","author":"P Gal","year":"1984","unstructured":"Gal P, et al. The influence of asphyxia on phenobarbital dosing requirements in neonates. Dev Pharmacol Ther. 1984;7(3):145\u201352.","journal-title":"Dev Pharmacol Ther"},{"issue":"4","key":"250_CR37","first-page":"318","volume":"8","author":"MC Nahata","year":"1988","unstructured":"Nahata MC, Masuoka T, Edwards RC. Developmental aspects of phenobarbital dosage requirements in newborn infants with seizures. J Perinatol. 1988;8(4):318\u201320.","journal-title":"J Perinatol"},{"issue":"Suppl 4","key":"250_CR38","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.33549\/physiolres.933213","volume":"64","author":"M Sima","year":"2015","unstructured":"Sima M, et al. Effect of co-medication on the pharmacokinetic parameters of phenobarbital in asphyxiated newborns. Physiol Res. 2015;64(Suppl 4):S513\u20139.","journal-title":"Physiol Res"},{"issue":"6","key":"250_CR39","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1542\/peds.75.6.1061","volume":"75","author":"SM Donn","year":"1985","unstructured":"Donn SM, Grasela TH, Goldstein GW. Safety of a higher loading dose of phenobarbital in the term newborn. Pediatrics. 1985;75(6):1061\u20134.","journal-title":"Pediatrics"},{"issue":"4","key":"250_CR40","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1528-1167.2011.02978.x","volume":"52","author":"L Filippi","year":"2011","unstructured":"Filippi L, et al. Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia. Epilepsia. 2011;52(4):794\u2013801.","journal-title":"Epilepsia"},{"issue":"2","key":"250_CR41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/PCC.0b013e31825bbbc2","volume":"14","author":"RA Shellhaas","year":"2013","unstructured":"Shellhaas RA, et al. Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia. Pediatr Crit Care Med. 2013;14(2):194\u2013202.","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"250_CR42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40262-012-0004-y","volume":"51","author":"MP Broek van den","year":"2012","unstructured":"van den Broek MP, et al. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach. Clin Pharmacokinet. 2012;51(10):671\u20139.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"250_CR43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","volume":"341","author":"MJ Painter","year":"1999","unstructured":"Painter MJ, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341(7):485\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"250_CR44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1542\/peds.83.5.674","volume":"83","author":"JT Gilman","year":"1989","unstructured":"Gilman JT, et al. Rapid sequential phenobarbital treatment of neonatal seizures. Pediatrics. 1989;83(5):674\u20138.","journal-title":"Pediatrics"},{"issue":"3","key":"250_CR45","doi-asserted-by":"crossref","first-page":"F165","DOI":"10.1136\/fn.86.3.F165","volume":"86","author":"GB Boylan","year":"2002","unstructured":"Boylan GB, et al. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed. 2002;86(3):F165\u201370.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"7","key":"250_CR46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, et al. Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49(7):1239\u201376.","journal-title":"Epilepsia"},{"issue":"6","key":"250_CR47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jpeds.2009.01.002","volume":"154","author":"LA Lockman","year":"2009","unstructured":"Lockman LA, Kriel R, Zaske D, Thompson T, Virnig N, Lawrence R, et al. A pilot study of continuous limited-channel aEEG in term infants with encephalopathy. J Pediatr. 2009;154(6):835\u201341.","journal-title":"J Pediatr"},{"issue":"3","key":"250_CR48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1651-2227.1975.tb03873.x","volume":"64","author":"B Jalling","year":"1975","unstructured":"Jalling B. Plasma concentrations of phenobarbital in the treatment of seizures in newborns. Acta Paediatr Scand. 1975;64(3):514\u201324.","journal-title":"Acta Paediatr Scand"},{"issue":"7","key":"250_CR49","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1212\/WNL.38.7.1035","volume":"38","author":"TO Crawford","year":"1988","unstructured":"Crawford TO, et al. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology. 1988;38(7):1035\u201340.","journal-title":"Neurology"},{"issue":"12","key":"250_CR50","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1212\/WNL.32.12.1401","volume":"32","author":"P Gal","year":"1982","unstructured":"Gal P, et al. Efficacy of phenobarbital monotherapy in treatment of neonatal seizures\u2014relationship to blood levels. Neurology. 1982;32(12):1401\u20134.","journal-title":"Neurology"},{"issue":"23","key":"250_CR51","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.222550499","volume":"99","author":"P Bittigau","year":"2002","unstructured":"Bittigau P, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA. 2002;99(23):15089\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"250_CR52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/jp.2013.116","volume":"33","author":"NL Maitre","year":"2013","unstructured":"Maitre NL, et al. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013;33(11):841\u20136.","journal-title":"J Perinatol"},{"issue":"6","key":"250_CR53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/01.ftd.0000249948.95749.f3","volume":"28","author":"M Al Za\u2019abi","year":"2006","unstructured":"Al Za\u2019abi M, et al. Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures. Ther Drug Monit. 2006;28(6):793\u20139.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"250_CR54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.yebeh.2010.12.011","volume":"20","author":"MA Mikati","year":"2011","unstructured":"Mikati MA, et al. Potential neuroprotective effects of continuous topiramate therapy in the developing brain. Epilepsy Behav. 2011;20(4):597\u2013601.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"250_CR55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1212\/WNL.33.2.173","volume":"33","author":"BF Bourgeois","year":"1983","unstructured":"Bourgeois BF, Dodson WE. Phenytoin elimination in newborns. Neurology. 1983;33(2):173\u20138.","journal-title":"Neurology"},{"issue":"6","key":"250_CR56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1440-1754.1995.tb00872.x","volume":"31","author":"A Bye","year":"1995","unstructured":"Bye A, Flanagan D. Electroencephalograms, clinical observations and the monitoring of neonatal seizures. J Paediatr Child Health. 1995;31(6):503\u20137.","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"250_CR57","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13312-013-0218-6","volume":"50","author":"G Pathak","year":"2013","unstructured":"Pathak G, et al. Phenobarbitone versus phenytoin for treatment of neonatal seizures: an open-label randomized controlled trial. Indian Pediatr. 2013;50(8):753\u20137.","journal-title":"Indian Pediatr"},{"issue":"1","key":"250_CR58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0387-7604(99)00110-2","volume":"22","author":"F Sicca","year":"2000","unstructured":"Sicca F, et al. Phenytoin administration in the newborn and infant. Brain Dev. 2000;22(1):35\u201340.","journal-title":"Brain Dev"},{"key":"250_CR59","unstructured":"Mihi S, Richardson H. Hypnotic and sedatives. In: Brunton BCL, Knollman B, editors. The pharmacological basis of therapeutics. New York, NY: McGraw Hill; 2011."},{"key":"250_CR60","doi-asserted-by":"crossref","first-page":"309342","DOI":"10.1155\/2014\/309342","volume":"2014","author":"GM Pacifici","year":"2014","unstructured":"Pacifici GM. Clinical pharmacology of midazolam in neonates and children: effect of disease-a review. Int J Pediatr. 2014;2014:309342.","journal-title":"Int J Pediatr"},{"issue":"1","key":"250_CR61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00044011-200323010-00004","volume":"23","author":"SN Wildt de","year":"2003","unstructured":"de Wildt SN, et al. Pharmacodynamics of intravenous and oral midazolam in preterm infants. Clin Drug Investig. 2003;23(1):27\u201338.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"250_CR62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00002826-199619020-00005","volume":"19","author":"RD Sheth","year":"1996","unstructured":"Sheth RD, et al. Midazolam in the treatment of refractory neonatal seizures. Clin Neuropharmacol. 1996;19(2):165\u201370.","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"250_CR63","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/01.WNL.0000152891.58694.71","volume":"64","author":"JR Castro Conde","year":"2005","unstructured":"Castro Conde JR, et al. Midazolam in neonatal seizures with no response to phenobarbital. Neurology. 2005;64(5):876\u20139.","journal-title":"Neurology"},{"issue":"2","key":"250_CR64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000368180","volume":"107","author":"MP Broek van den","year":"2015","unstructured":"van den Broek MP, et al. Anticonvulsant effectiveness and hemodynamic safety of midazolam in full-term infants treated with hypothermia. Neonatology. 2015;107(2):150\u20136.","journal-title":"Neonatology"},{"issue":"3","key":"250_CR65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0883073807299858","volume":"22","author":"E Shany","year":"2007","unstructured":"Shany E, Benzaqen O, Watemberg N. Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures. J Child Neurol. 2007;22(3):255\u20139.","journal-title":"J Child Neurol"},{"issue":"9","key":"250_CR66","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1651-2227.2004.tb02753.x","volume":"93","author":"K Leuven van","year":"2004","unstructured":"van Leuven K, et al. Midazolam and amplitude-integrated EEG in asphyxiated full-term neonates. Acta Paediatr. 2004;93(9):1221\u20137.","journal-title":"Acta Paediatr"},{"issue":"10","key":"250_CR67","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpedi.1986.02140240088032","volume":"140","author":"A Deshmukh","year":"1986","unstructured":"Deshmukh A, et al. Lorazepam in the treatment of refractory neonatal seizures. A pilot study. Am J Dis Child. 1986;140(10):1042\u20134.","journal-title":"Am J Dis Child"},{"issue":"2","key":"250_CR68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.38.2.202","volume":"38","author":"DM Shaner","year":"1988","unstructured":"Shaner DM, et al. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology. 1988;38(2):202\u20137.","journal-title":"Neurology"},{"issue":"6","key":"250_CR69","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.pediatrneurol.2015.02.019","volume":"52","author":"B Ozcan","year":"2015","unstructured":"Ozcan B, et al. Rhythmic myoclonic jerking induced by midazolam in a preterm infant. Pediatr Neurol. 2015;52(6):e9.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"250_CR70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ana.24601","volume":"79","author":"EG Duerden","year":"2016","unstructured":"Duerden EG, et al. Midazolam dose correlates with abnormal hippocampal growth and neurodevelopmental outcome in preterm infants. Ann Neurol. 2016;79(4):548\u201359.","journal-title":"Ann Neurol"},{"issue":"7","key":"250_CR71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.seizure.2011.04.004","volume":"20","author":"LJ Stephen","year":"2011","unstructured":"Stephen LJ, et al. Levetiracetam monotherapy\u2013outcomes from an epilepsy clinic. Seizure. 2011;20(7):554\u20137.","journal-title":"Seizure"},{"issue":"3","key":"250_CR72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/11316250-000000000-00000","volume":"12","author":"A Verrotti","year":"2010","unstructured":"Verrotti A, et al. Levetiracetam in childhood epilepsy. Paediatr Drugs. 2010;12(3):177\u201386.","journal-title":"Paediatr Drugs"},{"issue":"9","key":"250_CR73","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","volume":"14","author":"SM Bajjalieh","year":"1994","unstructured":"Bajjalieh SM, et al. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci. 1994;14(9):5223\u201335.","journal-title":"J Neurosci"},{"issue":"26","key":"250_CR74","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA. 2004;101(26):9861\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"250_CR75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","volume":"85","author":"PN Patsalos","year":"2000","unstructured":"Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 2000;85(2):77\u201385.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"250_CR76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1358\/mf.2003.25.2.723686","volume":"25","author":"PN Patsalos","year":"2003","unstructured":"Patsalos PN. The pharmacokinetic characteristics of levetiracetam. Methods Find Exp Clin Pharmacol. 2003;25(2):123\u20139.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"11","key":"250_CR77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","volume":"43","author":"PN Patsalos","year":"2004","unstructured":"Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet. 2004;43(11):707\u201324.","journal-title":"Clin Pharmacokinet"},{"key":"250_CR78","doi-asserted-by":"crossref","unstructured":"Merhar SL, et al. Pharmacokinetics of levetiracetam in neonates with seizures. J Pediatr. 2011;159(1):152\u2013154 e3.","DOI":"10.1016\/j.jpeds.2011.03.057"},{"issue":"1","key":"250_CR79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/pr.2012.51","volume":"72","author":"CM Sharpe","year":"2012","unstructured":"Sharpe CM, et al. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Res. 2012;72(1):43\u20139.","journal-title":"Pediatr Res"},{"issue":"4","key":"250_CR80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0883073810384263","volume":"26","author":"NS Abend","year":"2011","unstructured":"Abend NS, et al. Levetiracetam for treatment of neonatal seizures. J Child Neurol. 2011;26(4):465\u201370.","journal-title":"J Child Neurol"},{"issue":"8","key":"250_CR81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jocn.2012.08.014","volume":"20","author":"A Rakshasbhuvankar","year":"2013","unstructured":"Rakshasbhuvankar A, et al. Intravenous levetiracetam for treatment of neonatal seizures. J Clin Neurosci. 2013;20(8):1165\u20137.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"250_CR82","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0883073816678102","volume":"32","author":"C Venkatesan","year":"2017","unstructured":"Venkatesan C, et al. Levetiracetam for the treatment of seizures in neonatal hypoxic ischemic encephalopathy. J Child Neurol. 2017;32(2):210\u20134.","journal-title":"J Child Neurol"},{"issue":"3","key":"250_CR83","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2010.01.003","volume":"19","author":"A Furwentsches","year":"2010","unstructured":"Furwentsches A, et al. Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure. 2010;19(3):185\u20139.","journal-title":"Seizure"},{"issue":"3","key":"250_CR84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5409\/wjcp.v4.i3.45","volume":"4","author":"ML Yau","year":"2015","unstructured":"Yau ML, Fung EL, Ng PC. Response of levetiracetam in neonatal seizures. World J Clin Pediatr. 2015;4(3):45\u20139.","journal-title":"World J Clin Pediatr"},{"issue":"1","key":"250_CR85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/14767058.2014.986651","volume":"29","author":"G Loiacono","year":"2016","unstructured":"Loiacono G, et al. The treatment of neonatal seizures: focus on levetiracetam. J Matern Fetal Neonatal Med. 2016;29(1):69\u201374.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"250_CR86","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","volume":"44","author":"O Khan","year":"2011","unstructured":"Khan O, et al. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol. 2011;44(4):265\u20139.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"250_CR87","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/epi.13365","volume":"57","author":"S Kaushal","year":"2016","unstructured":"Kaushal S, et al. Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain. Epilepsia. 2016;57(5):727\u201334.","journal-title":"Epilepsia"},{"issue":"5","key":"250_CR88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.earlhumdev.2012.12.002","volume":"89","author":"H Kilicdag","year":"2013","unstructured":"Kilicdag H, et al. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev. 2013;89(5):355\u201360.","journal-title":"Early Hum Dev"},{"key":"250_CR89","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2016.05.040","volume":"1646","author":"K Strasser","year":"2016","unstructured":"Strasser K, et al. Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain. Brain Res. 2016;1646:116\u201324.","journal-title":"Brain Res"},{"key":"250_CR90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2015.12.001","volume":"770","author":"MD Donovan","year":"2016","unstructured":"Donovan MD, et al. In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide. Eur J Pharmacol. 2016;770:117\u201325.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"250_CR91","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","volume":"50","author":"JE Pina-Garza","year":"2009","unstructured":"Pina-Garza JE, et al. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia. 2009;50(5):1141\u20139.","journal-title":"Epilepsia"},{"issue":"7","key":"250_CR92","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/11589160-000000000-00000","volume":"50","author":"MP Broek van den","year":"2011","unstructured":"van den Broek MP, et al. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures. Clin Pharmacokinet. 2011;50(7):461\u20139.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"250_CR93","doi-asserted-by":"crossref","first-page":"F341","DOI":"10.1136\/archdischild-2012-302678","volume":"98","author":"MP Broek van den","year":"2013","unstructured":"van den Broek MP, et al. Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing. Arch Dis Child Fetal Neonatal Ed. 2013;98(4):F341\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"250_CR94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1651-2227.1988.tb10602.x","volume":"77","author":"L Hellstrom-Westas","year":"1988","unstructured":"Hellstrom-Westas L, et al. Lidocaine for treatment of severe seizures in newborn infants. I. Clinical effects and cerebral electrical activity monitoring. Acta Paediatr Scand. 1988;77(1):79\u201384.","journal-title":"Acta Paediatr Scand"},{"issue":"3","key":"250_CR95","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/01.WNL.0000106944.59990.E6","volume":"62","author":"GB Boylan","year":"2004","unstructured":"Boylan GB, et al. Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. Neurology. 2004;62(3):486\u20138.","journal-title":"Neurology"},{"issue":"9","key":"250_CR96","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00431-006-0136-x","volume":"165","author":"MM Malingre","year":"2006","unstructured":"Malingre MM, et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr. 2006;165(9):598\u2013604.","journal-title":"Eur J Pediatr"},{"issue":"9","key":"250_CR97","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/apa.12311","volume":"102","author":"M Lundqvist","year":"2013","unstructured":"Lundqvist M, et al. Efficacy and safety of lidocaine for treatment of neonatal seizures. Acta Paediatr. 2013;102(9):863\u20137.","journal-title":"Acta Paediatr"},{"issue":"2","key":"250_CR98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/epi.13286","volume":"57","author":"LC Weeke","year":"2016","unstructured":"Weeke LC, et al. Lidocaine response rate in aEEG-confirmed neonatal seizures: retrospective study of 413 full-term and preterm infants. Epilepsia. 2016;57(2):233\u201342.","journal-title":"Epilepsia"},{"issue":"11","key":"250_CR99","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00431-004-1513-y","volume":"163","author":"LG Rooij van","year":"2004","unstructured":"van Rooij LG, et al. Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment. Eur J Pediatr. 2004;163(11):637\u201341.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"250_CR100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000430767","volume":"108","author":"LC Weeke","year":"2015","unstructured":"Weeke LC, et al. Lidocaine-associated cardiac events in newborns with seizures: incidence, symptoms and contributing factors. Neonatology. 2015;108(2):130\u20136.","journal-title":"Neonatology"},{"issue":"3","key":"250_CR101","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejpn.2016.12.011","volume":"21","author":"B Bohnhorst","year":"2017","unstructured":"Bohnhorst B, Hartmann H, Lange M. Severe methemoglobinemia caused by continuous lidocaine infusion in a term neonate. Eur J Paediatr Neurol. 2017;21(3):576\u20139.","journal-title":"Eur J Paediatr Neurol"},{"issue":"12","key":"250_CR102","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1474-4422(06)70626-3","volume":"5","author":"Y Ben-Ari","year":"2006","unstructured":"Ben-Ari Y, Holmes GL. Effects of seizures on developmental processes in the immature brain. Lancet Neurol. 2006;5(12):1055\u201363.","journal-title":"Lancet Neurol"},{"issue":"11","key":"250_CR103","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","volume":"11","author":"VI Dzhala","year":"2005","unstructured":"Dzhala VI, et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med. 2005;11(11):1205\u201313.","journal-title":"Nat Med"},{"issue":"2","key":"250_CR104","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.21229","volume":"63","author":"VI Dzhala","year":"2008","unstructured":"Dzhala VI, Brumback AC, Staley KJ. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol. 2008;63(2):222\u201335.","journal-title":"Ann Neurol"},{"issue":"3","key":"250_CR105","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.3171\/FOC\/2008\/25\/9\/E22","volume":"25","author":"KT Kahle","year":"2008","unstructured":"Kahle KT, Staley KJ. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus. 2008;25(3):E22.","journal-title":"Neurosurg Focus"},{"issue":"4","key":"250_CR106","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0009-9236(96)90197-6","volume":"60","author":"JE Sullivan","year":"1996","unstructured":"Sullivan JE, et al. Pharmacokinetics of bumetanide in critically ill infants. Clin Pharmacol Ther. 1996;60(4):405\u201313.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"250_CR107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000244492","volume":"72","author":"AM Lopez-Samblas","year":"1997","unstructured":"Lopez-Samblas AM, et al. The pharmacokinetics of bumetanide in the newborn infant. Biol Neonate. 1997;72(5):265\u201372.","journal-title":"Biol Neonate"},{"issue":"3","key":"250_CR108","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jcph.596","volume":"56","author":"V Jullien","year":"2016","unstructured":"Jullien V, et al. Pilot evaluation of the population pharmacokinetics of bumetanide in term newborn infants with seizures. J Clin Pharmacol. 2016;56(3):284\u201390.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"250_CR109","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11596620-000000000-00000","volume":"14","author":"GM Pacifici","year":"2012","unstructured":"Pacifici GM. Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants. Paediatr Drugs. 2012;14(4):233\u201346.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"250_CR110","doi-asserted-by":"crossref","first-page":"e57148","DOI":"10.1371\/journal.pone.0057148","volume":"8","author":"RT Cleary","year":"2013","unstructured":"Cleary RT, et al. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures. PLoS One. 2013;8(3):e57148.","journal-title":"PLoS One"},{"issue":"9","key":"250_CR111","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1528-1167.2009.02048.x","volume":"50","author":"A Mazarati","year":"2009","unstructured":"Mazarati A, Shin D, Sankar R. Bumetanide inhibits rapid kindling in neonatal rats. Epilepsia. 2009;50(9):2117\u201322.","journal-title":"Epilepsia"},{"issue":"5","key":"250_CR112","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0883073809333526","volume":"24","author":"KT Kahle","year":"2009","unstructured":"Kahle KT, et al. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(\u2212) cotransporter NKCC1. J Child Neurol. 2009;24(5):572\u20136.","journal-title":"J Child Neurol"},{"issue":"5","key":"250_CR113","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","volume":"14","author":"RM Pressler","year":"2015","unstructured":"Pressler RM, et al. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial. Lancet Neurol. 2015;14(5):469\u201377.","journal-title":"Lancet Neurol"},{"key":"250_CR114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.02.006","volume":"117","author":"K Romermann","year":"2017","unstructured":"Romermann K, et al. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain. Neuropharmacology. 2017;117:182\u201394.","journal-title":"Neuropharmacology"},{"issue":"4","key":"250_CR115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00128072-200103040-00006","volume":"3","author":"D Ormrod","year":"2001","unstructured":"Ormrod D, McClellan K. Topiramate: a review of its use in childhood epilepsy. Paediatr Drugs. 2001;3(4):293\u2013319.","journal-title":"Paediatr Drugs"},{"key":"250_CR116","doi-asserted-by":"publisher","unstructured":"Pulman J, Hutton JL, Marson AG. Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2014;(2):CD001908. doi: 10.1002\/14651858.CD001908.pub2 .","DOI":"10.1002\/14651858.CD001908.pub2"},{"issue":"15","key":"250_CR117","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2165\/00003495-200767150-00008","volume":"67","author":"KA Lyseng-Williamson","year":"2007","unstructured":"Lyseng-Williamson KA, Yang LP. Topiramate: a review of its use in the treatment of epilepsy. Drugs. 2007;67(15):2231\u201356.","journal-title":"Drugs"},{"issue":"4","key":"250_CR118","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.siny.2013.04.005","volume":"18","author":"RM Pressler","year":"2013","unstructured":"Pressler RM, Mangum B. Newly emerging therapies for neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):216\u201323.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"250_CR119","first-page":"85","volume":"7","author":"JS Soul","year":"2009","unstructured":"Soul JS. Novel medications for neonatal seizures: bumetanide and topiramate. J Pediatr Neurol. 2009;7(1):85\u201393.","journal-title":"J Pediatr Neurol"},{"issue":"4","key":"250_CR120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00003088-200544040-00005","volume":"44","author":"D Battino","year":"2005","unstructured":"Battino D, et al. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data. Clin Pharmacokinet. 2005;44(4):407\u201316.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"250_CR121","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/epi.12019","volume":"54","author":"P Manitpisitkul","year":"2013","unstructured":"Manitpisitkul P, et al. Pharmacokinetics and safety of adjunctive topiramate in infants (1\u201324\u00a0months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Epilepsia. 2013;54(1):156\u201364.","journal-title":"Epilepsia"},{"issue":"11","key":"250_CR122","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1528-1167.2009.02302.x","volume":"50","author":"L Filippi","year":"2009","unstructured":"Filippi L, et al. Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. Epilepsia. 2009;50(11):2355\u201361.","journal-title":"Epilepsia"},{"key":"250_CR123","doi-asserted-by":"publisher","unstructured":"Filippi L et al. Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study. J Matern Fetal Neonatal Med. 2017;1\u20138. doi: 10.1080\/14767058.2017.1304536 .","DOI":"10.1080\/14767058.2017.1304536"},{"issue":"6","key":"250_CR124","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2011.01.006","volume":"44","author":"HC Glass","year":"2011","unstructured":"Glass HC, Poulin C, Shevell MI. Topiramate for the treatment of neonatal seizures. Pediatr Neurol. 2011;44(6):439\u201342.","journal-title":"Pediatr Neurol"},{"issue":"9","key":"250_CR125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3181d1cd4c","volume":"74","author":"E Novotny","year":"2010","unstructured":"Novotny E, et al. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology. 2010;74(9):714\u201320.","journal-title":"Neurology"},{"issue":"3","key":"250_CR126","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jpeds.2010.04.019","volume":"157","author":"L Filippi","year":"2010","unstructured":"Filippi L, et al. Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study. J Pediatr. 2010;157(3):361\u20136.","journal-title":"J Pediatr"},{"issue":"2","key":"250_CR127","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2004.01.025","volume":"187","author":"C Glier","year":"2004","unstructured":"Glier C, et al. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol. 2004;187(2):403\u20139.","journal-title":"Exp Neurol"},{"issue":"3","key":"250_CR128","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1533-2500.2004.04304.x","volume":"4","author":"KS Walia","year":"2004","unstructured":"Walia KS, et al. Side effects of antiepileptics\u2014a review. Pain Pract. 2004;4(3):194\u2013203.","journal-title":"Pain Pract"},{"issue":"7","key":"250_CR129","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1528-1157.2002.37201.x","volume":"43","author":"H Philippi","year":"2002","unstructured":"Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia. 2002;43(7):744\u20137.","journal-title":"Epilepsia"},{"issue":"5","key":"250_CR130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1542\/peds.102.5.1098","volume":"102","author":"AJ Gunn","year":"1998","unstructured":"Gunn AJ, et al. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep. Pediatrics. 1998;102(5):1098\u2013106.","journal-title":"Pediatrics"},{"key":"250_CR131","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2431-7-30","volume":"7","author":"SM Schulzke","year":"2007","unstructured":"Schulzke SM, Rao S, Patole SK. A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy\u2014are we there yet? BMC Pediatr. 2007;7:30.","journal-title":"BMC Pediatr"},{"issue":"6","key":"250_CR132","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archpediatrics.2011.1772","volume":"166","author":"MA Tagin","year":"2012","unstructured":"Tagin MA, et al. Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2012;166(6):558\u201366.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"250_CR133","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1152\/jn.00957.2006","volume":"97","author":"L Bennet","year":"2007","unstructured":"Bennet L, et al. Differential effects of hypothermia on early and late epileptiform events after severe hypoxia in preterm fetal sheep. J Neurophysiol. 2007;97(1):572\u20138.","journal-title":"J Neurophysiol"},{"issue":"1","key":"250_CR134","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.10402","volume":"53","author":"JR Tooley","year":"2003","unstructured":"Tooley JR, et al. Head cooling with mild systemic hypothermia in anesthetized piglets is neuroprotective. Ann Neurol. 2003;53(1):65\u201372.","journal-title":"Ann Neurol"},{"issue":"4","key":"250_CR135","doi-asserted-by":"crossref","first-page":"F267","DOI":"10.1136\/archdischild-2011-300716","volume":"97","author":"E Low","year":"2012","unstructured":"Low E, et al. Cooling and seizure burden in term neonates: an observational study. Arch Dis Child Fetal Neonatal Ed. 2012;97(4):F267\u201372.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"250_CR136","doi-asserted-by":"publisher","unstructured":"Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013;(1):CD003311. doi: 10.1002\/14651858.CD003311.pub2 .","DOI":"10.1002\/14651858.CD003311.pub2"},{"issue":"4 Spec No","key":"250_CR137","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/adc.64.4_Spec_No.459","volume":"64","author":"J Connell","year":"1989","unstructured":"Connell J, et al. Clinical and EEG response to anticonvulsants in neonatal seizures. Arch Dis Child. 1989;64(4 Spec No):459\u201364.","journal-title":"Arch Dis Child"},{"issue":"9","key":"250_CR138","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.braindev.2007.02.003","volume":"29","author":"H Yamamoto","year":"2007","unstructured":"Yamamoto H, et al. Treatments with midazolam and lidocaine for status epilepticus in neonates. Brain Dev. 2007;29(9):559\u201364.","journal-title":"Brain Dev"},{"issue":"5","key":"250_CR139","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00542419","volume":"30","author":"M Andre","year":"1986","unstructured":"Andre M, et al. Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures. Eur J Clin Pharmacol. 1986;30(5):585\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"250_CR140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/088307389100600406","volume":"6","author":"J Maytal","year":"1991","unstructured":"Maytal J, Novak GP, King KC. Lorazepam in the treatment of refractory neonatal seizures. J Child Neurol. 1991;6(4):319\u201323.","journal-title":"J Child Neurol"},{"issue":"1","key":"250_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","volume":"15","author":"G Ramantani","year":"2011","unstructured":"Ramantani G, et al. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol. 2011;15(1):1\u20137.","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"250_CR142","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pediatrneurol.2013.05.008","volume":"49","author":"O Khan","year":"2013","unstructured":"Khan O, et al. Role of intravenous levetiracetam for acute seizure management in preterm neonates. Pediatr Neurol. 2013;49(5):340\u20133.","journal-title":"Pediatr Neurol"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-017-0250-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-017-0250-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-017-0250-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T18:37:43Z","timestamp":1659292663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-017-0250-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":142,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1007\/s40272-017-0250-4","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}